Stock TOI THE ONCOLOGY INSTITUTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company The Oncology Institute, Inc.

Equities

TOI

US68236X1000

Healthcare Facilities & Services

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
1.18 USD -1.67% Intraday chart for The Oncology Institute, Inc. -0.84% -42.16%
Apr. 08 The Oncology Institute, Inc. Appoints Jordan McInerney as New Chief Development Officer CI
Apr. 04 The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California CI

Business Summary

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Number of employees: 800

Sales per Business

USD in Million2022Weight2023Weight Delta
Patient Services
65.8 %
167 66.1 % 214 65.8 % +28.01%
Dispensary
32.0 %
79 31.4 % 104 32.0 % +30.87%
Clinical Trials & Other
2.1 %
6 2.5 % 7 2.1 % +8.58%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
252 100.0 % 324 100.0 % +28.42%

Managers

Managers TitleAgeSince
Daniel Virnich CEO
 Chief Executive Officer 46 18-12-31
Mihir Shah DFI
 Director of Finance/CFO 45 22-04-03
Jeremy Castle COO
 Chief Operating Officer 41 23-09-04
Yale Podnos CTO
 Chief Tech/Sci/R&D Officer 54 21-10-31
Bradford Hively BRD
 Director/Board Member 45 18-12-31
Laura Szitar HRO
 Human Resources Officer - -
Cristina Green PRN
 Corporate Officer/Principal - 22-10-10
Mark Huppelsheuser LAW
 General Counsel - 21-11-11

Members of the board

Members of the board TitleAgeSince
Richard Barasch CHM
 Chairman 70 21-11-11
Mark Pacala BRD
 Director/Board Member 68 22-09-20
Bradford Hively BRD
 Director/Board Member 45 18-12-31
Gabe Ling BRD
 Director/Board Member 42 22-08-31
Maeve O'Meara BRD
 Director/Board Member 43 21-11-11
Mohit Kaushal BRD
 Director/Board Member 45 20-03-09
Anne McGeorge BRD
 Director/Board Member 63 21-11-11
Karen Johnson BRD
 Director/Board Member 63 21-11-11
Karen Johnson BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 76,047,178 50,829,652 ( 66.84 %) 1,733,774 ( 2.280 %) 66.69 %
Stock B 0 165,045 0 0

Shareholders

NameEquities%Valuation
M33 Growth LLC
20.69 %
15,256,383 20.69 % 24 M $
Havencrest Capital Management LLC
11.93 %
8,801,823 11.93 % 14 M $
Fidelity Management & Research Co. LLC
6.446 %
4,754,083 6.446 % 8 M $
Fog Ventures Investments LLC
6.285 %
4,634,908 6.285 % 7 M $
ROCA Partners LLC
5.573 %
4,109,771 5.573 % 6 M $
Richy Agajanian
4.835 %
3,565,652 4.835 % 6 M $
Deerfield Management Co. LP (Private Equity)
4.556 %
3,360,052 4.556 % 5 M $
Josh Arnold Investment Consultant LLC
2.517 %
1,856,329 2.517 % 3 M $
Vanguard Global Advisers LLC
2.410 %
1,777,393 2.410 % 3 M $
Balyasny Asset Management LP
1.699 %
1,253,037 1.699 % 2 M $
NameEquities%Valuation
Richard Barasch
8.923 %
8,923 8.923 % 14 098 $
NameEquities%Valuation
LMR Partners LLP
-
1,624,856 - 365 593 $
Deerfield Management Co. LP (Private Equity)
-
1,250,000 - 281 250 $
Josh Arnold Investment Consultant LLC
-
417,745 - 93 993 $
Walleye Capital LLC
-
393,545 - 88 548 $
Davidson Kempner Capital Management LP
-
318,710 - 71 710 $
Citadel Securities GP LLC
-
166,045 - 37 360 $
Cowen & Co. LLC
-
121,600 - 27 360 $
GLG Partners LP
-
88,824 - 19 985 $
Healthcare of Ontario Pension Plan Trust Fund
-
87,500 - 19 688 $
Difesa Capital Management LP
-
82,749 - 18 619 $

Company contact information

The Oncology Institute, Inc.

18000 Studebaker Road Suite 800

90703, Cerritos

+

http://www.theoncologyinstitute.com
address The Oncology Institute, Inc.(TOI)

Sector

Healthcare
Healthcare Services
Healthcare Providers & Services
Healthcare Facilities & Services
Other Healthcare Facilities & Services

Sales per Business

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.18 USD
Average target price
2.5 USD
Spread / Average Target
+111.86%
Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
THE ONCOLOGY INSTITUTE, INC. Stock The Oncology Institute, Inc.
-42.16% 87.69M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.87B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 83.08B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.72B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.4B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 15.04B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-3.97% 11.88B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.88B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.86B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. TOI Stock
  4. Company The Oncology Institute, Inc.